Starpharma Holdings Ltd (SPHRY)
0.7225
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Starpharma Holdings Price to Book Value: 1.268 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 1.268 |
| May 15, 2024 | 1.268 |
| May 14, 2024 | 1.268 |
| May 13, 2024 | 1.268 |
| May 10, 2024 | 1.266 |
| May 09, 2024 | 1.266 |
| May 08, 2024 | 1.266 |
| May 07, 2024 | 1.266 |
| May 06, 2024 | 1.523 |
| May 03, 2024 | 1.317 |
| May 02, 2024 | 1.317 |
| May 01, 2024 | 1.580 |
| April 30, 2024 | 1.580 |
| April 29, 2024 | 1.615 |
| April 26, 2024 | 1.615 |
| April 25, 2024 | 1.615 |
| April 24, 2024 | 1.492 |
| April 23, 2024 | 1.492 |
| April 22, 2024 | 1.492 |
| April 19, 2024 | 1.580 |
| April 18, 2024 | 1.580 |
| April 17, 2024 | 1.600 |
| April 16, 2024 | 1.510 |
| April 15, 2024 | 1.510 |
| April 12, 2024 | 1.510 |
| Date | Value |
|---|---|
| April 11, 2024 | 1.510 |
| April 10, 2024 | 1.510 |
| April 09, 2024 | 1.510 |
| April 08, 2024 | 1.510 |
| April 05, 2024 | 1.510 |
| April 04, 2024 | 1.492 |
| April 03, 2024 | 1.492 |
| April 02, 2024 | 1.440 |
| April 01, 2024 | 1.440 |
| March 28, 2024 | 1.440 |
| March 27, 2024 | 1.440 |
| March 26, 2024 | 1.440 |
| March 25, 2024 | 1.440 |
| March 22, 2024 | 1.440 |
| March 21, 2024 | 1.492 |
| March 20, 2024 | 1.492 |
| March 19, 2024 | 1.440 |
| March 18, 2024 | 1.440 |
| March 15, 2024 | 1.527 |
| March 14, 2024 | 1.570 |
| March 13, 2024 | 1.638 |
| March 12, 2024 | 1.580 |
| March 11, 2024 | 1.598 |
| March 08, 2024 | 1.615 |
| March 07, 2024 | 1.633 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.266
Minimum
May 07 2024
24.13
Maximum
Dec 29 2020
7.875
Average
7.548
Median
Apr 06 2020
Price to Book Value Benchmarks
| Alterity Therapeutics Ltd | -- |
| Kazia Therapeutics Ltd | 2.166 |
| Immutep Ltd | -- |
| Opthea Ltd | -- |
| Mesoblast Ltd | -- |
Price to Book Value Related Metrics
| PS Ratio | 5.002 |
| Price | 0.7225 |
| Earnings Yield | -20.46% |
| Market Cap | 29.77M |